The official description: “The DrugSafetyHub blog aims to foster an open industry exchange on the subject of diverted and counterfeit prescription drugs in the pharmaceutical supply chain and the safety threats they pose to patients and consumers.”
DSH is a “hosted discussion,” which means there are multiple bloggers (8 so far). Check out the list of contributors – a veritable who’s who of pharma industry blogging! I’ll be writing a combination of proprietary material for the blog as well as occasionally cross-posting material from Drug Channels.
The site is sponsored by e-pedigree software vendor Supplyscape, but I have been assured that the content and topics will be free from any editorial meddling. The official blog policy reiterates this message with 9 cluetrain-worthy principles. As always, I'll call it as I see it.
Check it out for yourself and let me know what you think.